Astellas and MBC BioLabs Announce the Sixth Annual Astellas Future Innovator Prize
Astellas Pharma and MBC BioLabs have announced their sixth annual Astellas Future Innovator Prize competition. The prize offers emerging biotech startups and entrepreneurial scientists one year of priority access to MBC BioLabs' advanced Bay Area facilities, along with access to Astellas' R&D capabilities and business expertise.
The initiative aims to accelerate early drug discovery and research efforts, supporting the development of novel therapeutic programs, modalities, and platforms. Last year's winners were Tipping Point Biosciences and Altay Therapeutics, selected for their potential to address unmet medical needs.
Interested participants have until April 1, 2025 to submit their non-confidential company presentations, including a one-page executive summary.
Astellas Pharma e MBC BioLabs hanno annunciato il loro sesto concorso annuale per il Astellas Future Innovator Prize. Il premio offre a startup biotech emergenti e scienziati imprenditoriali un anno di accesso prioritario alle avanzate strutture di MBC BioLabs nella Bay Area, insieme all'accesso alle capacità di R&S di Astellas e alla sua expertise commerciale.
L'iniziativa mira ad accelerare la scoperta e la ricerca di farmaci precoci, supportando lo sviluppo di nuovi programmi terapeutici, modalità e piattaforme. I vincitori dello scorso anno sono stati Tipping Point Biosciences e Altay Therapeutics, selezionati per il loro potenziale di affrontare bisogni medici non soddisfatti.
I partecipanti interessati hanno tempo fino al 1 aprile 2025 per presentare le loro presentazioni aziendali non riservate, inclusa una sintesi esecutiva di una pagina.
Astellas Pharma y MBC BioLabs han anunciado su sexto concurso anual del Astellas Future Innovator Prize. El premio ofrece a startups biotecnológicas emergentes y a científicos emprendedores un año de acceso prioritario a las avanzadas instalaciones de MBC BioLabs en el Área de la Bahía, junto con acceso a las capacidades de I+D de Astellas y su experiencia empresarial.
La iniciativa tiene como objetivo acelerar el descubrimiento temprano de medicamentos y los esfuerzos de investigación, apoyando el desarrollo de nuevos programas terapéuticos, modalidades y plataformas. Los ganadores del año pasado fueron Tipping Point Biosciences y Altay Therapeutics, seleccionados por su potencial para abordar necesidades médicas no satisfechas.
Los participantes interesados tienen hasta el 1 de abril de 2025 para presentar sus presentaciones empresariales no confidenciales, incluida un resumen ejecutivo de una página.
아스텔라스 제약과 MBC 바이오랩스가 제6회 연례 아스텔라스 미래 혁신가 상 공모전을 발표했습니다. 이 상은 신생 생명공학 스타트업과 기업가 과학자에게 MBC 바이오랩스의 첨단 베이 지역 시설에 1년간 우선적으로 접근할 수 있는 기회를 제공하며, 아스텔라스의 연구개발 능력과 비즈니스 전문성에도 접근할 수 있습니다.
이 이니셔티브는 초기 약물 발견 및 연구 노력을 가속화하여 새로운 치료 프로그램, 방식 및 플랫폼의 개발을 지원하는 것을 목표로 합니다. 지난해 수상자는 티핑 포인트 바이오사이언스와 알타이 치료제로, 이들은 충족되지 않은 의료 요구를 해결할 잠재력으로 선택되었습니다.
관심 있는 참가자는 2025년 4월 1일까지 비밀이 아닌 회사 발표 자료를 제출해야 하며, 1페이지 분량의 요약을 포함해야 합니다.
Astellas Pharma et MBC BioLabs ont annoncé leur sixième concours annuel du Astellas Future Innovator Prize. Ce prix offre aux startups biotechnologiques émergentes et aux scientifiques entrepreneurs un an d'accès prioritaire aux installations avancées de MBC BioLabs dans la région de la Baie, ainsi qu'un accès aux capacités de R&D d'Astellas et à son expertise commerciale.
L'initiative vise à accélérer la découverte précoce de médicaments et les efforts de recherche, en soutenant le développement de nouveaux programmes thérapeutiques, modalités et plateformes. Les gagnants de l'année dernière étaient Tipping Point Biosciences et Altay Therapeutics, sélectionnés pour leur potentiel à répondre aux besoins médicaux non satisfaits.
Les participants intéressés ont jusqu'au 1er avril 2025 pour soumettre leurs présentations d'entreprise non confidentielles, y compris un résumé exécutif d'une page.
Astellas Pharma und MBC BioLabs haben ihren sechsten jährlichen Wettbewerb um den Astellas Future Innovator Prize angekündigt. Der Preis bietet aufstrebenden Biotech-Startups und unternehmerischen Wissenschaftlern ein Jahr lang priorisierten Zugang zu den fortschrittlichen Einrichtungen von MBC BioLabs in der Bay Area sowie Zugang zu den F&E-Kapazitäten und der Geschäftsexpertise von Astellas.
Die Initiative zielt darauf ab, die frühe Medikamentenentdeckung und Forschungsbemühungen zu beschleunigen und die Entwicklung neuartiger therapeutischer Programme, Modalitäten und Plattformen zu unterstützen. Die Gewinner des letzten Jahres waren Tipping Point Biosciences und Altay Therapeutics, die aufgrund ihres Potenzials zur Deckung unerfüllter medizinischer Bedürfnisse ausgewählt wurden.
Interessierte Teilnehmer haben bis zum 1. April 2025 Zeit, ihre nicht vertraulichen Unternehmenspräsentationen einzureichen, einschließlich einer einseitigen Zusammenfassung.
- Strategic investment in early-stage biotech innovation and R&D pipeline development
- Strengthening presence in biotech startup ecosystem
- None.
- Awardees win a year of access to a prestigious life-science incubator in
San Francisco and to Astellas expertise to further their research - Award helps biotech start-ups accelerate early drug discovery and research efforts
With a shared commitment to discovering and advancing innovative science for patients worldwide, Astellas and MBC BioLabs are continuing to support scientists and early-stage companies to accelerate their novel therapeutic programs, modalities and platforms. Last year's winners were Tipping Point Biosciences and Altay Therapeutics. They were chosen for the potential of their innovations to deliver therapeutic advances for unmet medical needs.
Issei Tsukamoto, Head, Business Development at Astellas
"Through our strong collaboration with MBC BioLabs, and providing the right expertise, resources, and support, we aim to empower innovators to turn their vision into breakthroughs that can make a meaningful impact and improve patient lives worldwide."
Doug Crawford, General Manager at MBC BioLabs
"We are very proud to partner with Astellas in helping advise and support early-stage innovators. The Astellas Future Innovator Prize is a great example of this work as recipients can receive Astellas' assistance, guidance and expertise alongside our co-working labs."
Entrepreneurial scientists, emerging life-science and biotechnology start-ups have until April 1, 2025 to enter the Astellas Future Innovator Prize by submitting their non-confidential company presentation, including a one-page executive summary here.
About the Astellas Future Innovator Prize at MBC BioLabs
Astellas is offering up to two prizes for pioneering scientists with innovative research ideas that complement Astellas' areas of interest in alignment with its Focus Area Approach and pipeline, including Blindness & Beyond, Genetic Regulation, Immuno-Oncology, Cell Therapy, Targeted Protein Degradation, and other areas.
Companies awarded an Astellas Future Innovator Prize will gain a one-year priority admission or renewal to MBC BioLabs' state-of-the-art laboratory and access to Astellas' R&D scientists and business leaders. The competition is open from February 27 to April 1, 2025. Entrepreneurial scientists, emerging life-science and biotechnology start-ups should submit their non-confidential company presentation, including a one-page executive summary, here to be considered. The decision to award any Astellas Future Innovator Prize and the assessments underlying such decision, are solely within the judgment of Astellas and are not subject to any objection or appeal.
For further information, please visit the Astellas Future Innovator website where you can also find submission guidance for your non-confidential company presentation and executive summary.
About Astellas
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology, and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Learn more at www.astellas.com.
About MBC BioLabs
MBC BioLabs believes startups are the greatest force for positive change in the world. We offer flexible state-of-the-art lab space, facilities, access to millions of dollars in equipment and instrumentation, along with a vibrant community of like-minded individuals tackling some of the world's biggest problems. We are dedicated to helping biotech startups succeed – we enable awesome. We have helped launch and grow over 350 companies since opening in October of 2013, and together, MBC companies have initiated 176 clinical trials, introduced 71 products to market, and raised nearly
Cautionary Notes (Astellas)
In this press release, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas. These statements are based on management's current assumptions and beliefs in light of the information currently available to it and involve known and unknown risks and uncertainties. A number of factors could cause actual results to differ materially from those discussed in the forward-looking statements. Such factors include, but are not limited to: (i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue to effectively research and develop products accepted by customers in highly competitive markets, and (vi) infringements of Astellas' intellectual property rights by third parties. Information about pharmaceutical products (including products currently in development) which is included in this press release is not intended to constitute an advertisement or medical advice.
View original content to download multimedia:https://www.prnewswire.com/news-releases/astellas-and-mbc-biolabs-announce-the-sixth-annual-astellas-future-innovator-prize-302382687.html
SOURCE Astellas Pharma Inc.
FAQ
What does the Astellas Future Innovator Prize 2025 (ALPMY) offer to winners?
When is the submission deadline for the 2025 Astellas (ALPMY) Future Innovator Prize?
Who won the previous Astellas (ALPMY) Future Innovator Prize?
How can startups apply for the 2025 Astellas (ALPMY) Future Innovator Prize?
